MARKET

MAACW

MAACW

MONTES ARCHIMEDE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.300
-0.150
-10.34%
Closed 16:00 05/07 EDT
OPEN
1.360
PREV CLOSE
1.450
HIGH
1.400
LOW
1.300
VOLUME
118.29K
TURNOVER
--
52 WEEK HIGH
2.150
52 WEEK LOW
0.5800
MARKET CAP
--
P/E (TTM)
-173.3333
1D
5D
1M
3M
1Y
5Y
Deals of the day-Mergers and acquisitions
reuters.com · 6d ago
BRIEF-Montes Archimedes Acquisition Says Roivant Is Expected To Have An Initial Market Capitalization Of $7.3 Billion
reuters.com · 6d ago
UPDATE 1-Biotech firm Roivant Sciences to go public via $7.3 bln SPAC deal
reuters.com · 6d ago
Biotech Roivant to go public via $7.3 bln SPAC deal
reuters.com · 6d ago
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MAACW. Analyze the recent business situations of MONTES ARCHIMEDE through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About MAACW
Montes Archimedes Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus its search on identifying a target business in health care ecosystem.

Webull offers kinds of Montes Archimedes Acquisition Corp stock information, including NASDAQ:MAACW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MAACW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MAACW stock methods without spending real money on the virtual paper trading platform.